Response from the authors
Dear Sir, We are most interested in the comments of Dr. L. O. Simpson regarding the importance of intracapillary blood constituents and endothelial cells in the damaging effects of capillary disease in diabetic nerve. We would agree with the opinion that this is probably just as important as the abnormal haemodynamics in the vessels supplying the nerve. In the original studies of sural nerve biopsies where capillary endothelial changes were noted [1] [2] [3] many of the vessels showed debris which was undoubtedly of cellular nature with fibrin and in some instances small plugs of deactivated platelets. However, we would agree that the haemodynamic factors within the nerve are extremely difficult to assess in vivo. We would suggest that there is an urgent 
The cumulative incidence of childhood diabetes mellitus in Sweden unaffected by BCG-vaccination
Dear Sir, Several studies in the diabetes-prone nonobese diabetic (NOD) mouse have shown that even one single injection of either complete Freund's adjuvant (CFA) [1] or BCG-vaccine [2] given at an early age prevented the development of diabetes in this animal model. The mechanism has been indicated to be due to a non-specific stimulation of natural suppressor activity. Recently, Shehadeh et al. [3] reported that CFA and BCG vaccine modulated the development of diabetes melli- Based on these indications several large-scale placebo-controlled trials have been started in diabetic humans including children with primary prevention in healthy children as a goal. In Sweden, since 1 July 1977 we have continuously registered all childhood-onset diabetic cases with a level of ascertainment close to 99 % [4] . Before 1975 all newborn babies in Sweden were offered BCG-vaccination (using the dose given above) in the first month of life and the coverage of this vaccination programme was almost complete [5, 6] . Due to side effects, in some cases severe complications, this policy was stopped on 1 April 1975. Since then only high-risk groups such as immigrant children or children with a close relative with tuberculosis have been vaccinated. In 1976 only 0.6 % were vaccinated [5] and between 1976-1980 less than 2 % were vacci-nated [6]. When comparing cumulative incidence rates of IDDM up to 15 years of age between birth cohorts 1973, 1974 and 1976, 1977 (Fig. 1) there is clearly no significant difference. As can be seen, the cumulative incidence was slightly lower during 1974 whereas 1973, 1976 and 1977 are almost identical. Since the incidence registration of childhood diabetes started on 1 July 1977 cumulative incidence rates in children with disease onset before the age of 4 years could not be compared. The proportion of diabetic patients in these agegroups is, however, very low, between 10-15 % (e. g. 46/367 in 1977). An effect of BCG vaccination on the incidence of IDDM in very young-onset diabetic patients thus could not be excluded but would not account for a large proportion of cases.
We conclude that, on a population basis, BCG-vaccination in newborn children seems to have no significant effect on the incidence of childhood-onset IDDM and therefore would not offer an effective primary prevention strategy. 
